6.5 Million Patients
Affected By Chronic Wounds in The U.S.
Costing $50 Billion Annually1
Why Health Plans Should Reconsider
Wound Care Treatment...
Chronic wounds represent a large and growing threat to public health. As the population ages, that burden will increase - made worse by rising healthcare costs and the growing incidences of diabetes and obesity.2
Proven Clinical and Economic Results
In a randomized controlled trial (RCT) (V.A.C.® Therapy: n=169, AMWT: n=166), V.A.C.® Therapy resulted in a significantly greater proportion of foot ulcers achieving complete closure and fewer amputations at 112 days compared to advanced moist wound therapy (AMWT).9
Optum™ LifeSciences case study: A comparison of health care costs and hospital readmission rates associated with Negative Pressure Wound Therapies U.S. claims data were analyzed by Optum™ LifeSciences for over 15,000 patients with at least one NPWT claim in the post-acute setting to identify total cost of care for KCI V.A.C.® Therapy vs. Competitor NPWT patients. 10
Active Monitoring In 2017, KCI provided iOn PROGRESS™ Remote Therapy Monitoring to > 1,200 patients in different geographies across the US. Here's what happend: